197 related articles for article (PubMed ID: 32332753)
1. Non-coding somatic mutations converge on the PAX8 pathway in ovarian cancer.
Corona RI; Seo JH; Lin X; Hazelett DJ; Reddy J; Fonseca MAS; Abassi F; Lin YG; Mhawech-Fauceglia PY; Shah SP; Huntsman DG; Gusev A; Karlan BY; Berman BP; Freedman ML; Gayther SA; Lawrenson K
Nat Commun; 2020 Apr; 11(1):2020. PubMed ID: 32332753
[TBL] [Abstract][Full Text] [Related]
2. Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.
Jones MR; Peng PC; Coetzee SG; Tyrer J; Reyes ALP; Corona RI; Davis B; Chen S; Dezem F; Seo JH; Kar S; Dareng E; ; Berman BP; Freedman ML; Plummer JT; Lawrenson K; Pharoah P; Hazelett DJ; Gayther SA
Am J Hum Genet; 2020 Oct; 107(4):622-635. PubMed ID: 32946763
[TBL] [Abstract][Full Text] [Related]
3. Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients.
Zhang L; Luo M; Yang H; Zhu S; Cheng X; Qing C
J Ovarian Res; 2019 Feb; 12(1):19. PubMed ID: 30786925
[TBL] [Abstract][Full Text] [Related]
4. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
5. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.
Kar SP; Adler E; Tyrer J; Hazelett D; Anton-Culver H; Bandera EV; Beckmann MW; Berchuck A; Bogdanova N; Brinton L; Butzow R; Campbell I; Carty K; Chang-Claude J; Cook LS; Cramer DW; Cunningham JM; Dansonka-Mieszkowska A; Doherty JA; Dörk T; Dürst M; Eccles D; Fasching PA; Flanagan J; Gentry-Maharaj A; Glasspool R; Goode EL; Goodman MT; Gronwald J; Heitz F; Hildebrandt MA; Høgdall E; Høgdall CK; Huntsman DG; Jensen A; Karlan BY; Kelemen LE; Kiemeney LA; Kjaer SK; Kupryjanczyk J; Lambrechts D; Levine DA; Li Q; Lissowska J; Lu KH; Lubiński J; Massuger LF; McGuire V; McNeish I; Menon U; Modugno F; Monteiro AN; Moysich KB; Ness RB; Nevanlinna H; Paul J; Pearce CL; Pejovic T; Permuth JB; Phelan C; Pike MC; Poole EM; Ramus SJ; Risch HA; Rossing MA; Salvesen HB; Schildkraut JM; Sellers TA; Sherman M; Siddiqui N; Sieh W; Song H; Southey M; Terry KL; Tworoger SS; Walsh C; Wentzensen N; Whittemore AS; Wu AH; Yang H; Zheng W; Ziogas A; Freedman ML; Gayther SA; Pharoah PD; Lawrenson K
Br J Cancer; 2017 Feb; 116(4):524-535. PubMed ID: 28103614
[TBL] [Abstract][Full Text] [Related]
7. TEAD4 regulates trophectoderm differentiation upstream of CDX2 in a GATA3-independent manner in the human preimplantation embryo.
Stamatiadis P; Cosemans G; Boel A; Menten B; De Sutter P; Stoop D; Chuva de Sousa Lopes SM; Lluis F; Coucke P; Heindryckx B
Hum Reprod; 2022 Jul; 37(8):1760-1773. PubMed ID: 35700449
[TBL] [Abstract][Full Text] [Related]
8. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
9. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium.
Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE
Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide analysis of Pax8 binding provides new insights into thyroid functions.
Ruiz-Llorente S; Carrillo Santa de Pau E; Sastre-Perona A; Montero-Conde C; Gómez-López G; Fagin JA; Valencia A; Pisano DG; Santisteban P
BMC Genomics; 2012 Apr; 13():147. PubMed ID: 22531031
[TBL] [Abstract][Full Text] [Related]
11. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
12. Alternatively Constructed Estrogen Receptor Alpha-Driven Super-Enhancers Result in Similar Gene Expression in Breast and Endometrial Cell Lines.
Bojcsuk D; Nagy G; Bálint BL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32120995
[TBL] [Abstract][Full Text] [Related]
13. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
14. PAX8 regulon in human ovarian cancer links lineage dependency with epigenetic vulnerability to HDAC inhibitors.
Shi K; Yin X; Cai MC; Yan Y; Jia C; Ma P; Zhang S; Zhang Z; Gu Z; Zhang M; Di W; Zhuang G
Elife; 2019 May; 8():. PubMed ID: 31050342
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA SNGH7 Is activated by SP1 and exerts oncogenic properties by interacting with EZH2 in ovarian cancer.
Bai Z; Wu Y; Bai S; Yan Y; Kang H; Ma W; Zhang J; Gao Y; Hui B; Ma H; Li R; Zhang X; Ren J
J Cell Mol Med; 2020 Jul; 24(13):7479-7489. PubMed ID: 32420685
[TBL] [Abstract][Full Text] [Related]
16. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma.
de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M
Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239
[TBL] [Abstract][Full Text] [Related]
17. Specific chromatin landscapes and transcription factors couple breast cancer subtype with metastatic relapse to lung or brain.
Cai WL; Greer CB; Chen JF; Arnal-Estapé A; Cao J; Yan Q; Nguyen DX
BMC Med Genomics; 2020 Mar; 13(1):33. PubMed ID: 32143622
[TBL] [Abstract][Full Text] [Related]
18. Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer.
Leitner K; Tsibulak I; Wieser V; Knoll K; Reimer D; Marth C; Fiegl H; Zeimet AG
Sci Rep; 2020 Nov; 10(1):20412. PubMed ID: 33230143
[TBL] [Abstract][Full Text] [Related]
19. Expression of WT1 and PAX8 in the epithelial tumours of Malaysian women with ovarian cancer.
Rhodes A; Vallikkannu N; Jayalakshmi P
Br J Biomed Sci; 2017 Apr; 74(2):65-70. PubMed ID: 28367736
[TBL] [Abstract][Full Text] [Related]
20. Adipose-derived mesenchymal stem cells induced PAX8 promotes ovarian cancer cell growth by stabilizing TAZ protein.
Chu Y; Zhu C; Wang Q; Liu M; Wan W; Zhou J; Han R; Yang J; Luo W; Liu C; Zhou H; Li M; Yu F; Ye Y
J Cell Mol Med; 2021 May; 25(9):4434-4443. PubMed ID: 33830648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]